(Q50995074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

0 references

1 reference

cognitive dysfunction

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Elen V Fagherazzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Vanessa A Garcia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Natasha Maurmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Thielly Bervanger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Luis H Halmenschlager

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Stefano B Busato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jaime E Hallak

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Antônio W Zuardi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

José A Crippa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

26 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1133-1140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-011-2449-3

11 February 2020

exact match

0 references

cites work

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Neonatal iron exposure induces oxidative stress in adult Wistar rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Recognition memory impairment and brain oxidative stress induced by postnatal iron administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Reversal of age-related deficits in object recognition memory in rats with l-deprenyl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Reversion of age-related recognition memory impairment by iron chelation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Early post-natal iron administration induces astroglial response in the brain of adult and aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Reversal of age-associated memory impairment by rosuvastatin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Memory deficits in adult rats following postnatal iron administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Cannabidiol for the treatment of psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2449-3

Cannabinoids for the treatment of dementia

21 January 2018

1 reference

12 December 2020

Therapeutical use of the cannabinoids in psychiatry

1 reference

12 December 2020

Cannabidiol: a promising drug for neurodegenerative disorders?

1 reference

12 December 2020

Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol

1 reference

12 December 2020

Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron

1 reference

12 December 2020

10.1007/S00213-011-2449-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870037%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference